ParkinsonV1, France, Analysis, indexHead, KwdEn.i

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

121	Parkinson's disease
25	deep brain stimulation
20	subthalamic nucleus
15	dopamine
14	levodopa
14	Parkinson disease
11	Parkinson
10	Parkinson’s disease
9	rating scales
9	depression
9	dementia
8	substantia nigra
8	basal ganglia
8	Alzheimer's disease
7	parkinsonism
7	dopamine agonists
6	neuroprotection
6	dyskinesia
6	clinimetrics
6	apomorphine
5	treatment
5	motor fluctuations
5	dopamine agonist
5	apathy
5	UPDRS = Unified Parkinson's Disease Rating Scale
4	validity
4	striatum
4	reliability
4	psychometrics
4	piribedil
4	motor complications
4	Dopamine
3	subthalamic nucleus stimulation
3	quality of life
3	neurosurgery
3	neurodegeneration
3	multiple system atrophy
3	movement disorders
3	monotherapy
3	impulsivity
3	globus pallidus
3	freezing of gait
3	executive functions
3	evidence‐based medicine
3	epidemiology
3	diagnostic criteria
3	diagnosis
3	cognition
3	cell death
3	PD, Parkinson’s disease
3	MPTP
3	L‐dopa
2	vision
2	transcranial magnetic stimulation
2	stimulation
2	sleep
2	serotonin
2	ropinirole
2	review
2	rasagiline
2	psychosis
2	plasticity
2	pharmacotherapy
2	partial dopamine agonist
2	parkin
2	noradrenaline
2	neurotoxicity
2	neuropsychology
2	mutation
2	mouse
2	motivation
2	mortality
2	monoamine oxidase inhibitors
2	microsubthalamotomy
2	memory
2	management guideline
2	maladie de Parkinson
2	magnetic resonance imaging
2	limbic system
2	human brain
2	glucocerebrosidase
2	gait disorders
2	gait analysis
2	fluoroscopy
2	event related potentials
2	environmental exposure
2	entacapone
2	dystonia
2	dyskinesias
2	continuous dopaminergic stimulation
2	clozapine
2	clinical trial
2	caudate nucleus
2	autonomic failure
2	assessment
2	anticholinergics
2	animal models
2	amantadine
2	Tyrosine hydroxylase
2	STN stimulation
2	STN = subthalamic nucleus
2	Ropinirole
2	Parkinsonism
2	Parkinson's disease dementia
2	Parkin
2	Multiple system atrophy
2	Lewy bodies
2	Levodopa
2	Human
1	〚18F〛-fluoro-L-Dopa
1	〚18F〛-desoxyglucose
1	〚15O〛-H2O
1	〚123〛-β-CIT
1	〚123I〛-FP-β-CIT
1	〚11C〛-Raclopride
1	α‐synuclein
1	α-Synuclein
1	α synuclein
1	worm
1	working memory
1	word generation
1	wearing‐off
1	wearing off
1	wavelets
1	voluntary movement
1	visual memory
1	visual manipulation
1	virus
1	viral vectors
1	vessie neurologique
1	vervet monkey
1	vertebral fractures
1	verb
1	ventral intermedius
1	vascular dementia
1	validation
1	unsteadiness
1	tyrosine hydroxylase
1	tricyclics
1	tricyclic antidepressants
1	transgenic
1	thrombosis
1	therapy adherence
1	thalamotomy
1	thalamic deep brain stimulation
1	tauopathies
1	task force
1	tachycardie supraventriculaire
1	tachycardia, supraventricular
1	synucléine α
1	synuclein
1	syndrome frontal
1	syndrome extrapyramidal
1	symptoms
1	symptomatic effect
1	switch trial
1	surgical complications
1	supraventricutar tachycardia
1	supraventricular tachycardia
1	sudden onset of sleep episodes
1	subthalamic
1	subthalamic stimulation
1	substantia innominata
1	subcortical dementia
1	studies in families
1	stroke
1	stride length
1	striatofrontal circuits
1	stereotaxy
1	stereotaxis
1	stepping test
1	staircase test
1	spontaneous activity
1	sphingomyelinase
1	speech
1	speech therapy
1	spatial orientation
1	smoking
1	sleep disorders
1	skin
1	single photon emission computed tomography (SPECT)
1	side‐effects
1	sialorrhea
1	sepiapterin reductase
1	selegiline
1	selective serotonin reuptake inhibitors (SSRIs)
1	screening procedures
1	scales
1	safety and tolerability
1	saccades
1	rythme mu
1	risk factors
1	reward
1	restless legs syndrome
1	regional
1	regional anaesthetic technique
1	rat
1	randomized controlled trial
1	randomized controlled clinical trial
1	radioimmunoassay
1	quinolinic acid
1	questionnaires
1	putamen
1	publication guidelines
1	psychiatric status rating scales
1	préparation motrice
1	protease
1	promoter
1	progressive supranuclear palsy
1	procedural learning
1	pro-opiomelanocortin
1	primate
1	prevalence
1	pregnancy
1	predictive factors
1	pramipexole‐extended release
1	pramipexole
1	pramipexole extended‐release
1	pramipexole extended release
1	potentiels évoqués
1	postural instability
1	postural control
1	postsynaptic densities
1	positron emission tomography (PET)
1	population isolate
1	poor metabolizer alleles
1	polymorphisms
1	physiotherapy
1	physical therapy
1	phosphate buffer
1	phincter-detrusor dyssynergia
1	pharmacovigilance
1	pharmacology
1	pharmacokinetics
1	pesticides
1	perseveration
1	peroxidase-antiperoxidase
1	pergolide
1	perceptual and semantic processes
1	perampanel
1	patient‐reported outcomes
1	pathophysiology
1	pathological gambling
1	parkinson's disease
1	parkine
1	parkin, PARK2
1	parkin coregulated gene, PACRG
1	pardoprunox
1	pardoprunox (SLV308)
1	pallidal stimulation
1	pain perception
1	overexpression
1	orthostatic tremor
1	orthostatic symptoms
1	orthostatic hypotension
1	omega‐3 fatty‐acids
1	olfaction
1	ocular disease
1	occupational therapy
1	occupation
1	obturator nerve
1	obturator canal
1	nursing home
1	norepinephrine
1	non‐motor
1	nonmotor symptoms
1	nonmotor fluctuations
1	nonfluctuating patients
1	nocturnal disturbances
1	nociceptive flexion reflex
1	nitric oxide
1	neurotransplantation
1	neuropsychological outcome
1	neurophysiology
1	neuronal cells
1	neuroleptics
1	neuroinflammation
1	neurogenic bladder
1	neurogenetic
1	neurodegenerative diseases
1	neuroblastoma cells
1	network analysis
1	neglect
1	nNOS
1	myoclonus
1	mutations D6‐A, B, C, D, and T
1	muscarinic receptors
1	multiple‐system atrophy
1	multiple sclerosis
1	mu rhythm
1	mouvement volontaire
1	motor thalamus
1	motor preparation
1	motor execution
1	motor cortex
1	morbid risk
1	monoclonal antibody
1	monoamine oxidase B inhibitors
1	molecular diagnosis
1	mitochondrial
1	mirror reading
1	mild cognitive impairment
1	microtubule‐associated protein tau
1	microstimulation
1	microelectrode recording
1	meta‐analysis
1	mesencephalon
1	melanoma
1	measures
1	management
1	macrostimulation
1	lupus
1	locus coeruleus
1	linkage disequilibrium
1	limbic
1	lift force
1	levodopa‐related motor complications
1	levodopa-induced dyskinaesias
1	language
1	l-Dopa
1	interaction
1	infant
1	indications
1	inborn genetic diseases
1	in situ hybridization
1	iNOS
1	hypothalamus
1	hypersomnia
1	human
1	human pharmacokinetics
1	hippocampus
1	high‐frequency stimulation
1	heat wave
1	health‐related quality of life
1	health care costs
1	head trauma
1	haploinsufficiency
1	hallucinations
1	hallucination
1	génétique
1	guideline
1	grip force
1	grafting
1	glutathione
1	glutamate
1	globus pallidus internus
1	genotyping array
1	genotype/phenotype correlation
1	genotype-phenotype correlations
1	genome‐wide association
1	genome-wide linkage study
1	genetics
1	genetic
1	genetic epidemiology
1	gel filtration
1	gastrointestinal dysautonomia
1	gait initiation
1	functional dissociation
1	frontotemporal dementia with parkinsonism linked to chromosome 17
1	frontosubthalamic pathway
1	frontostriatal circuit
1	frontal syndrome
1	frontal dysfunction
1	frequency analysis
1	founder effect
1	food habits
1	fly
1	fetal neural transplants.
1	fetal mesencephalic tissue.
1	festination
1	fatigue
1	fatigue rating scales
1	fast Fourier transform
1	familial Parkinson's disease
1	extrapyramidal syndrome
1	exercise
1	excessive daytime sleepiness
1	event related desynchronization
1	enzyme replacement therapy
1	enteric nervous system
1	electrophysiology
1	early-onset parkinsonism
1	early treatment
1	early onset
1	early diagnosis
1	eNOS
1	désynchronisation liée à l'événement
1	démence sous-corticale
1	dyssynergie vésicosphinctérienne
1	dysphagia
1	dysexecutive syndrome
1	dysarthria
1	duplication
1	duodenal infusion
1	drug safety
1	dopaminergic systems
1	dopaminergic antagonists
1	dopaminergic agonist
1	dopamine transporter
1	dopamine receptor
1	disease modification
1	disability
1	dihydroxyphenylacetic acid
1	digoxine
1	digoxin
1	diffusion‐weighted imaging
1	differential diagnosis
1	deprenyl
1	dendritic spines
1	dementia with Lewy bodies
1	delusion
1	delay‐discounting
1	delayed‐start
1	delayed start design
1	delayed non‐matching‐to‐sample task
1	deep brain stimulation surgery
1	daytime sleepiness
1	cytochrome P450 CYP2D6 gene
1	cross sectional survey
1	corticobasal degeneration
1	cortical areas
1	corrélations génotype-phénotype
1	contrôle postural
1	contrast sensitivity
1	contraindications
1	continuous SC infusion
1	constipation
1	conditional motor learning
1	computerized EEG
1	community
1	cognitive functions
1	clinical progression
1	circling behaviour
1	chronic pain
1	chorea
1	choline acetyltransferase
1	chip
1	cerebrospinal fluid
1	cerebral metabolism
1	cerebral cortex
1	cerebral blood flow (rCBF)
1	catechol‐O‐methyl transferase inhibitors
1	catecholmethyltransferase inhibitors
1	catecholamines
1	case–control
1	case‐control
1	cardiac sympathetic innervation
1	cardiac MIBG scintigraphy
1	cannabinoid receptors
1	cancer
1	calcium
1	calcium channel blockers
1	calbindin
1	butyrylcholinesterase
1	bromocriptine
1	bolus injection
1	behavior
1	basal ganglia frontal loops
1	balance test
1	bacterial artificial chromosome (BAC)
1	axial motor symptoms
1	awareness
1	autophagy
1	autonomic nervous system
1	atrioventricular (AV) node reentry
1	apoptosis
1	anxiety
1	anti‐inflammatory agents, nonsteroidal
1	antipsychotics
1	antiphospholipid
1	antidepressant treatment
1	antibody
1	anhedonia
1	amiodarone
1	alpha‐synuclein
1	akinesia
1	agriculture
1	ageing
1	age
1	age at onset
1	adverse drug reactions
1	addiction
1	acupuncture
1	activities of daily living
1	activation
1	acetylcholinesterase
1	accessory pathway
1	abnormal movements
1	ablation
1	[3H]SR142948A
1	Wolff‐Parkinson‐White syndrome
1	Wolff-Parkinson-White syndrome
1	Wolff-Parkinson-White (syndrome de)
1	WCST = Wisconsin Card Sorting Test
1	WAIS-R = Wechsler Adult Intelligence Scale—revised
1	Vim
1	Ventral striatum
1	VTA
1	VIQ = verbal intelligence quotient
1	VIP

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/Parkinson.storage/ParkinsonV1/Data/France/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024

	Serveur d'exploration sur la maladie de Parkinson - Analysis (France) Index « Mots-clés originaux en anglais » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la maladie de Parkinson - Analysis (France)Index « Mots-clés originaux en anglais » - tête de navigation

Index : Keywords

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration sur la maladie de Parkinson - Analysis (France)

Index « Mots-clés originaux en anglais » - tête de navigation